Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
Fevipiprant is used in the oral treatment of asthma and has been successful in targeting severe eosinophilic asthma. Fevipiprant is a novel oral prostaglandin D2 receptor 2 (DP2; known as CRTh2) antagonist and currently in development for the treatment of severe asthma and atopic dermatitis.
您的位置：
